Toxoplasma gondii Triggers Phosphorylation and Nuclear Translocation of Dendritic Cell STAT1 while Simultaneously Blocking IFNγ-Induced STAT1 Transcriptional Activity

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Schneider, Anne G ^a   Abi Abdallah, Delbert S ^a   Butcher, Barbara A ^a   Denkers, Eric Y ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; PROTEIN KINASE; ROP16 PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DENDRITIC CELL; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IRF 1 GENE; LRG47 GENE; MOUSE; NONHUMAN; PARASITE PHENOMENA AND FUNCTIONS; PARASITE REPLICATION; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TOXOPLASMA GONDII;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELLS; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTOZOAN PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TOXOPLASMOSIS; TRANSCRIPTION, GENETIC;

EID: 84875199094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060215     Document Type: Article

References (62)

1. Hill DE, Chirukandoth S, Dubey JP, (2005) Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 6: 41-61.
2. Weiss LM, Dubey JP, (2009) Toxoplasmosis: A history of clinical observations. Int J Parasitol 39: 895-901.
3. Kaye A, (2011) Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J Pediatr Health Care 25: 355-364.
4. Howe DK, Sibley LD, (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human diseases. J Infect Dis 172: 1561-1566.
5. Sibley LD, Boothroyd JC, (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
6. Boothroyd JC, Grigg ME, (2002) Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Micro 5: 438-442.
7. Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, et al. (2011) Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 41: 645-655.
8. Dubey JP, Velmurugan GV, Rajendran C, Yabsley MJ, Thomas NJ, et al. (2011) Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol 41: 1139-1147.
9. Suzuki Y, Orellana MA, Schreiber RD, Remington JS, (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
10. McCabe RE, Luft BJ, Remington JS, (1984) Effect of murine interferon gamma on murine toxoplasmosis. J Infect Dis 150: 961-962.
11. Scharton-Kersten TM, Wynn TA, Denkers EY, Bala S, Grunvald E, et al. (1996) In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 157: 4045-4054.
12. Nathan CF, Murray HW, Wiebe ME, Rubin BY, (1983) Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158: 670-689.
13. Murray HW, Rubin BY, Carriero SM, Harris AM, Jaffee EA, (1985) Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol 134: 1982-1988.
14. Murray HW, Spitalny GL, Nathan CF, (1985) Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol 134: 1619-1622.
15. Taylor GA, Feng CG, Sher A, (2004) p47 GTPases: regulators of immunity to intracellular pathogens. Nat Rev Immunol 4: 100-109.
16. Taylor GA, (2007) IRG proteins: key mediators of interferon-regulated host resistance to intracellular pathogens. Cell Microbiol 9: 1099-1107.
17. Collazo CM, Yap GS, Sempowski GD, Lusby KC, Tessarollo L, et al. (2001) Inactivation of LRG-47 and IRG-47 reveals a family of interferon-γ-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med 194: 181-187.
18. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
19. Durbin JE, Hackenmiller R, Simon MC, Levy DE, (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
20. Gavrilescu LC, Butcher BA, Del Rio L, Taylor GA, Denkers EY, (2004) STAT1 Is Essential for Antimicrobial Effector Function but Dispensable for Gamma Interferon Production during Toxoplasma gondii Infection. Infection and Immunity 72: 1257-1264.
21. Lieberman LA, Banica M, Reiner SL, Hunter CA, (2004) STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J Immunol 172: 457-463.
22. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW, (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285: 1-24.
23. Stark GR, (2007) How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev 18: 419-423.
24. Murray PJ, (2007) The JAK-STAT signaling pathway: input and output integration. J Immunol 178: 2623-2629.
25. Wen Z, Zhong Z, Darnell JE Jr, (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.
26. Wen Z, Darnell JE Jr, (1997) Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res 25: 2062-2067.
27. Zhu X, Wen Z, Xu LZ, Darnell JE Jr, (1997) Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase. Mol Cell Biol 17: 6618-6623.
28. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, et al. (2001) Biologic consequences of Stat1-independent IFN-γ signaling. Proc Natl Acad Sci USA 98: 6680-6685.
29. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N, (2001) IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19: 623-655.
30. Khan IA, Matsuura T, Fonseka S, Kasper LH, (1996) Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. J Immunol 156: 636-643.
31. Luder CG, Lang T, Beuerle B, Gross U, (1998) Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol 112: 308-316.
32. Luder CGK, Walter W, Beuerle B, Maeurer MJ, Gross U, (2001) Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1α. Eur J Immunol 31: 1475-1484.
33. Yang TH, Aosai F, Norose K, Ueda M, Yano A, (1996) Differential regulation of HLA-DR expression and antigen presentation in Toxoplasma gondii-infected melanoma cells by interleukin 6 and interferon gamma. Microbiol Immunol 40: 443-449.
34. Seabra SH, de Souza W, DaMatta RA, (2002) Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Exp Parasitol 100: 62-70.
35. Luder CGK, Algner M, Lang C, Bleicher N, Gross U, (2003) Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages. Internat J Parasitol 33: 833-844.
36. Luder CG, Lang C, Giraldo-Velasquez M, Algner M, Gerdes J, et al. (2003) Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA. J Neuroimmunol 134: 12-24.
37. Rozenfeld C, Martinez R, Seabra S, Sant'anna C, Goncalves JG, et al. (2005) Toxoplasma gondii prevents neuron degeneration by interferon-gamma-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-beta1 production by infected microglia. Am J Pathol 167: 1021-1031.
38. Lang C, Algner M, Beinert N, Gross U, Luder CG, (2006) Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Microbes Infect 8: 1994-2005.
39. Zimmermann S, Murray PJ, Heeg K, Dalpke AH, (2006) Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J Immunol 176: 1840-1847.
40. Kim SK, Fouts AE, Boothroyd JC, (2007) Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J Immunol 178: 5154-5165.
41. Lang C, Hildebrandt A, Brand F, Opitz L, Dihazi H, et al. (2012) Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-Infected macrophages to IFN-gamma. PLoS Pathog 8: e1002483.
42. Rosowski EE, Saeij JP, (2012) Toxoplasma gondii Clonal Strains All Inhibit STAT1 Transcriptional Activity but Polymorphic Effectors Differentially Modulate IFNgamma Induced Gene Expression and STAT1 Phosphorylation. PLoS One 7: e51448.
43. Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A, (2006) Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 8: 1611-1623.
44. Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, et al. (2006) CD11c and CD11b expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 107: 309-316.
45. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli A, Denkers EY, (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181: 8445-8491.
46. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S, (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667.
47. Liu CH, Fan YT, Dias A, Esper L, Corn RA, et al. (2006) Cutting Edge: Dendritic Cells Are Essential for In Vivo IL-12 Production and Development of Resistance against Toxoplasma gondii Infection in Mice. J Immunol 177: 31-35.
48. Mashayekhi M, Sandau MM, Dunay IR, Frickel EM, Khan A, et al. (2011) CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35: 249-259.
49. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr, (1992) Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258: 1808-1812.
50. Dobrowolski JM, Sibley LD, (1996) Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84: 933-939.
51. Fox BA, Bzik DJ, (2002) De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature 415: 926-929.
52. Yamamoto M, Standley DM, Takashima S, Saiga H, Okuyama M, et al. (2009) A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. J Exp Med 206: 2747-2760.
53. Ong YC, Reese ML, Boothroyd JC, (2010) Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. J Biol Chem 285: 28731-28740.
54. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maurer KJ, et al. (2011) Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog 7: e1002236.
55. Jensen KD, Wang Y, Wojno ED, Shastri AJ, Hu K, et al. (2011) Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. Cell Host Microbe 9: 472-483.
56. Decker T, Kovarik P, Meinke A, (1997) GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17: 121-134.
57. Taylor GA, Collazo CM, Yap GS, Nguyen K, Gregorio TA, et al. (2000) Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP. Proc Natl Acad Sci USA 97: 751-755.
58. Collazo CM, Yap GS, Hieny S, Caspar P, Feng CG, et al. (2002) The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and non-hematopoietic cellular compartments. Infect Immun 70: 6933-6939.
59. Leng J, Butcher BA, Egan CE, Abdallah DS, Denkers EY, (2009) Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation. J Immunol 182: 489-497.
60. Leng J, Denkers EY, (2009) Toxoplasma gondii inhibits covalent modification of histone H3 at the IL-10 promoter in infected macrophages. PLoS One 4: e7589.
61. Carruthers VB, Sibley LD, (1997) Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Biol 73: 114-123.
62. Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, et al. (2011) Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med 208: 195-212.